fda warning compounded semaglutide safety 2024 2025 Drug Recalls and Warnings: Recalls for and Tirzepatide, Wegovy; Facility Letters Pharmacovigilance Assessment of Compounded GLP-1

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

This can be a serious side effect

Also, compounded drugs may be useful in times of drug shortages

Any cognitive benefits would be secondary and not guaranteed

If you need significant weight loss results comparable to what tirzepatide before and after outcomes deliver, a probiotic is not going to provide that level of impact

PubMed, Embase, and the Cochrane Library were searched using keyword combinations related to GLP-1 receptor agonists, dual GLP-1/GIP agonists, and GI adverse events, from the inception of the database up to March 2025